Hypoglycemia: New Definitions and Regulatory Implications.

Lipid Profiles, Inflammatory Markers, and Insulin Therapy in Youth with Type 2 Diabetes.

Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial.

Cardiac Biomarkers in Youth with Type 2 Diabetes Mellitus: Results from the TODAY Study.

Statin use and risk of developing diabetes: results from the Diabetes Prevention Program.

Should We Screen for Type 2 Diabetes?

Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.

Evaluating the Quality of Comprehensive Cardiometabolic Care for Patients With Type 2 Diabetes in the U.S.: The Diabetes Collaborative Registry.

Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW.

Pregnancy Outcomes in Youth With Type 2 Diabetes: The TODAY Study Experience.

American Diabetes Association and JDRF Research Symposium: Diabetes and the Microbiome.

Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.

The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome.

Biologic Responses to Weight Loss and Weight Regain: Report From an American Diabetes Association Research Symposium.

A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study.